ChemicalBook >> CAS DataBase List >>GGTI-2154 hydrochloride

GGTI-2154 hydrochloride

CAS No.
478908-50-8
Chemical Name:
GGTI-2154 hydrochloride
Synonyms
GGTI-2154 hydrochloride;L-Leucine, N-[[5-[(1H-imidazol-4-ylmethyl)amino]-2′-methyl[1,1′-biphenyl]-2-yl]carbonyl]-, monohydrochloride
CBNumber:
CB313259795
Molecular Formula:
Molecular Weight:
456.97
MDL Number:
MOL File:
478908-50-8.mol
MSDS File:
SDS
Last updated:2026-07-16 07:06:08

GGTI-2154 hydrochloride Properties

form Solid
color White to off-white

GGTI-2154 hydrochloride price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0173740 GGTI-2154 hydrochloride 98.08% 478908-50-8 5mg $672 2026-06-04 Buy
ChemScene CS-0173740 GGTI-2154 hydrochloride 98.08% 478908-50-8 10mg $1062 2026-06-04 Buy
ChemScene CS-0173740 GGTI-2154 hydrochloride 98.08% 478908-50-8 25mg $2112 2026-06-04 Buy
ChemScene CS-0173740 GGTI-2154 hydrochloride 98.08% 478908-50-8 50mg $3521 2026-06-04 Buy
ChemScene CS-0173740 GGTI-2154 hydrochloride 98.08% 478908-50-8 100mg $5633 2026-06-04 Buy
Product number Packaging Price Buy
CS-0173740 5mg $672 Buy
CS-0173740 10mg $1062 Buy
CS-0173740 25mg $2112 Buy
CS-0173740 50mg $3521 Buy
CS-0173740 100mg $5633 Buy

GGTI-2154 hydrochloride Chemical Properties,Uses,Production

Uses

GGTI-2154 hydrochloride is a potent and selective inhibitor geranylgeranyltransferase I (GGTase I), with an IC50 of 21 nM. GGTI-2154 hydrochloride shows more than 200-fold selectivity for GGTase I over FTase (IC50=5600 nM). GGTI-2154 hydrochloride can be used for the research of cancer[1][2].

in vivo

GGTI-2154 (100 mg/kg/day; s.c. for 14 days) induces breast tumor regression in MMTV-ν-Ha-Ras transgenic mice[2].
GGTI-2154 (50 mg/kg/day; i.p. for 50 day) inhibits A-549 tumor growth in nude mice by 60%[1].

Animal Model:MMTV-v-Ha-ras transgenic mice bearing mammary carcinoma[2]
Dosage:100 mg/kg/day
Administration:S.c. with osmotic mini-pumps for 14 days
Result:Halted the tumors aggressive growth.
Resulted in rapid tumor regression within 3 days of initiation of drug treatment.

References

[1] Sun J, et, al. Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine. Cancer Res. 1999 Oct 1;59(19):4919-26. PMID:10519405
[2] Sun J, et, al. Geranylgeranyltransferase I inhibitor GGTI-2154 induces breast carcinoma apoptosis and tumor regression in H-Ras transgenic mice. Cancer Res. 2003 Dec 15;63(24):8922-9. PMID:14695209

GGTI-2154 hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

GGTI-2154 hydrochloride Suppliers

Global( 6)Suppliers
Supplier Tel Email Country ProdList Advantage
BOC Sciences 1-631-485-4226; 16314854226 info@bocsci.com United States 9920 65
Guangzhou Younan Technology Co., Ltd 020-82000279 18988941452 YN_research@163.com China 2984 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 29874 58
TargetMol Chemicals Inc. +1-781-999-5354; support@targetmol.com United States 38999 58
Aladdin Scientific tp@aladdinsci.com United States 50089 58

View Lastest Price from GGTI-2154 hydrochloride manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
GGTI-2154 hydrochloride pictures 2026-07-15 GGTI-2154 hydrochloride
478908-50-8
$1980.00-2690.00 10g TargetMol Chemicals Inc.
GGTI-2154 hydrochloride L-Leucine, N-[[5-[(1H-imidazol-4-ylmethyl)amino]-2′-methyl[1,1′-biphenyl]-2-yl]carbonyl]-, monohydrochloride 478908-50-8